HCA Healthcare, Inc. (0J1R.L)
USD 301.91
(-1.94%)
USD 301.91
(-1.94%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.02 Billion USD | -2.27% |
| 2022 | 2.06 Billion USD | 4.13% |
| 2021 | 1.98 Billion USD | -1.93% |
| 2020 | 2.02 Billion USD | 9.52% |
| 2019 | 1.84 Billion USD | 6.76% |
| 2018 | 1.73 Billion USD | 10.11% |
| 2017 | 1.57 Billion USD | 4.66% |
| 2016 | 1.5 Billion USD | 4.45% |
| 2015 | 1.43 Billion USD | 12.51% |
| 2014 | 1.27 Billion USD | 8.48% |
| 2013 | 1.17 Billion USD | 8.56% |
| 2012 | 1.08 Billion USD | 3.04% |
| 2011 | 1.05 Billion USD | 17.5% |
| 2010 | 897 Million USD | 11.85% |
| 2009 | 802 Million USD | 8.82% |
| 2008 | 737 Million USD | 3.8% |
| 2007 | 710 Million USD | 6.13% |
| 2006 | 669 Million USD | 8.6% |
| 2005 | 616 Million USD | 6.76% |
| 2004 | 577 Million USD | 10.96% |
| 2003 | 520 Million USD | 12.55% |
| 2002 | 462 Million USD | 9.22% |
| 2001 | 423 Million USD | 6.82% |
| 2000 | 396 Million USD | 3.39% |
| 1999 | 383 Million USD | -11.75% |
| 1998 | 434 Million USD | -3.98% |
| 1997 | 452 Million USD | 2.49% |
| 1996 | 441 Million USD | 8.62% |
| 1995 | 406 Million USD | 42.46% |
| 1994 | 285 Million USD | 16.33% |
| 1993 | 245 Million USD | 768.79% |
| 1992 | 28.2 Million USD | 147.37% |
| 1991 | 11.4 Million USD | 35.71% |
| 1990 | 8.4 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1.9 Billion USD | -5.84% |
| 2024 Q3 | 1.77 Billion USD | -1.33% |
| 2024 Q2 | 1.8 Billion USD | -5.41% |
| 2023 FY | 2.02 Billion USD | -2.27% |
| 2023 Q2 | 2.05 Billion USD | -1.68% |
| 2023 Q1 | 2.08 Billion USD | 0.82% |
| 2023 Q3 | 2.03 Billion USD | -0.98% |
| 2023 Q4 | 2.02 Billion USD | -0.44% |
| 2022 FY | 2.06 Billion USD | 4.13% |
| 2022 Q3 | 2 Billion USD | -1.66% |
| 2022 Q4 | 2.06 Billion USD | 2.94% |
| 2022 Q1 | 2 Billion USD | 0.86% |
| 2022 Q2 | 2.04 Billion USD | 2.0% |
| 2021 FY | 1.98 Billion USD | -1.93% |
| 2021 Q1 | 2.06 Billion USD | 2.12% |
| 2021 Q2 | 2.02 Billion USD | -1.98% |
| 2021 Q3 | 2.01 Billion USD | -0.39% |
| 2021 Q4 | 1.98 Billion USD | -1.63% |
| 2020 Q1 | 1.95 Billion USD | 5.62% |
| 2020 FY | 2.02 Billion USD | 9.52% |
| 2020 Q4 | 2.02 Billion USD | 3.85% |
| 2020 Q2 | 1.83 Billion USD | -6.09% |
| 2020 Q3 | 1.95 Billion USD | 6.32% |
| 2019 Q1 | 1.77 Billion USD | 2.66% |
| 2019 Q2 | 1.82 Billion USD | 2.7% |
| 2019 Q4 | 1.84 Billion USD | 4.52% |
| 2019 Q3 | 1.76 Billion USD | -3.12% |
| 2019 FY | 1.84 Billion USD | 6.76% |
| 2018 Q3 | 1.63 Billion USD | -0.12% |
| 2018 Q2 | 1.63 Billion USD | -2.44% |
| 2018 Q4 | 1.73 Billion USD | 6.0% |
| 2018 FY | 1.73 Billion USD | 10.11% |
| 2018 Q1 | 1.67 Billion USD | 6.61% |
| 2017 FY | 1.57 Billion USD | 4.66% |
| 2017 Q1 | 1.5 Billion USD | -0.13% |
| 2017 Q2 | 1.54 Billion USD | 2.86% |
| 2017 Q3 | 1.54 Billion USD | 0.13% |
| 2017 Q4 | 1.57 Billion USD | 1.75% |
| 2016 Q4 | 1.5 Billion USD | 0.0% |
| 2016 Q3 | 1.5 Billion USD | 1.49% |
| 2016 Q1 | 1.41 Billion USD | -1.67% |
| 2016 FY | 1.5 Billion USD | 4.45% |
| 2016 Q2 | 1.48 Billion USD | 4.66% |
| 2015 FY | 1.43 Billion USD | 12.51% |
| 2015 Q2 | 1.34 Billion USD | 4.74% |
| 2015 Q1 | 1.28 Billion USD | 0.63% |
| 2015 Q4 | 1.43 Billion USD | 4.35% |
| 2015 Q3 | 1.37 Billion USD | 2.3% |
| 2014 Q1 | 1.18 Billion USD | 0.68% |
| 2014 Q2 | 1.21 Billion USD | 2.02% |
| 2014 Q4 | 1.27 Billion USD | 1.67% |
| 2014 FY | 1.27 Billion USD | 8.48% |
| 2014 Q3 | 1.25 Billion USD | 3.88% |
| 2013 Q1 | 1.1 Billion USD | 1.66% |
| 2013 FY | 1.17 Billion USD | 8.56% |
| 2013 Q2 | 1.15 Billion USD | 4.35% |
| 2013 Q3 | 1.13 Billion USD | -1.48% |
| 2013 Q4 | 1.17 Billion USD | 3.88% |
| 2012 Q2 | 1.05 Billion USD | 0.86% |
| 2012 FY | 1.08 Billion USD | 3.04% |
| 2012 Q4 | 1.08 Billion USD | 3.23% |
| 2012 Q3 | 1.05 Billion USD | -0.28% |
| 2012 Q1 | 1.04 Billion USD | -0.76% |
| 2011 Q2 | 887 Million USD | 0.68% |
| 2011 Q1 | 881 Million USD | -1.78% |
| 2011 FY | 1.05 Billion USD | 17.5% |
| 2011 Q4 | 1.05 Billion USD | 18.29% |
| 2011 Q3 | 891 Million USD | 0.45% |
| 2010 Q1 | 794 Million USD | -1.0% |
| 2010 FY | 897 Million USD | 11.85% |
| 2010 Q4 | 897 Million USD | 10.06% |
| 2010 Q3 | 815 Million USD | 1.24% |
| 2010 Q2 | 805 Million USD | 1.39% |
| 2009 Q4 | 802 Million USD | 7.65% |
| 2009 Q2 | 730 Million USD | 1.81% |
| 2009 Q1 | 717 Million USD | -2.71% |
| 2009 Q3 | 745 Million USD | 2.05% |
| 2009 FY | 802 Million USD | 8.82% |
| 2008 Q2 | 715 Million USD | 1.42% |
| 2008 Q1 | 705 Million USD | -0.7% |
| 2008 Q4 | 737 Million USD | 2.93% |
| 2008 Q3 | 716 Million USD | 0.14% |
| 2008 FY | 737 Million USD | 3.8% |
| 2007 Q3 | 689 Million USD | 0.0% |
| 2007 FY | 710 Million USD | 6.13% |
| 2007 Q2 | 689 Million USD | 1.92% |
| 2007 Q4 | 710 Million USD | 3.05% |
| 2007 Q1 | 676 Million USD | 1.05% |
| 2006 Q2 | 646 Million USD | 3.53% |
| 2006 Q3 | 659 Million USD | 2.01% |
| 2006 Q4 | 669 Million USD | 1.52% |
| 2006 FY | 669 Million USD | 8.6% |
| 2006 Q1 | 624 Million USD | 1.3% |
| 2005 Q3 | 584 Million USD | 0.69% |
| 2005 Q4 | 616 Million USD | 5.48% |
| 2005 FY | 616 Million USD | 6.76% |
| 2005 Q1 | 577 Million USD | 0.0% |
| 2005 Q2 | 580 Million USD | 0.52% |
| 2004 Q1 | 532 Million USD | 2.31% |
| 2004 FY | 577 Million USD | 10.96% |
| 2004 Q4 | 577 Million USD | 6.07% |
| 2004 Q3 | 544 Million USD | 0.55% |
| 2004 Q2 | 541 Million USD | 1.69% |
| 2003 FY | 520 Million USD | 12.55% |
| 2003 Q3 | 491 Million USD | -0.41% |
| 2003 Q4 | 520 Million USD | 5.91% |
| 2003 Q2 | 493 Million USD | 6.71% |
| 2003 Q1 | 462 Million USD | 0.0% |
| 2002 FY | 462 Million USD | 9.22% |
| 2002 Q4 | 462 Million USD | 5.48% |
| 2002 Q3 | 438 Million USD | 0.92% |
| 2002 Q2 | 434 Million USD | 2.12% |
| 2002 Q1 | 425 Million USD | 0.47% |
| 2001 Q2 | 405 Million USD | 2.02% |
| 2001 Q1 | 397 Million USD | 0.25% |
| 2001 FY | 423 Million USD | 6.82% |
| 2001 Q4 | 423 Million USD | 5.22% |
| 2001 Q3 | 402 Million USD | -0.74% |
| 2000 Q3 | 383 Million USD | -1.54% |
| 2000 Q2 | 389 Million USD | 3.18% |
| 2000 Q1 | 377 Million USD | -1.57% |
| 2000 FY | 396 Million USD | 3.39% |
| 2000 Q4 | 396 Million USD | 3.39% |
| 1999 FY | 383 Million USD | -11.75% |
| 1999 Q1 | 419 Million USD | -3.46% |
| 1999 Q2 | 370 Million USD | -11.69% |
| 1999 Q4 | 383 Million USD | 4.36% |
| 1999 Q3 | 367 Million USD | -0.81% |
| 1998 FY | 434 Million USD | -3.98% |
| 1998 Q4 | 434 Million USD | -2.25% |
| 1998 Q1 | 463 Million USD | 2.43% |
| 1998 Q2 | 462 Million USD | -0.22% |
| 1998 Q3 | 444 Million USD | -3.9% |
| 1997 Q4 | 452 Million USD | -1.31% |
| 1997 FY | 452 Million USD | 2.49% |
| 1997 Q2 | 457 Million USD | 3.16% |
| 1997 Q1 | 443 Million USD | 0.45% |
| 1997 Q3 | 458 Million USD | 0.22% |
| 1996 Q3 | 432 Million USD | 0.23% |
| 1996 Q2 | 431 Million USD | 3.36% |
| 1996 Q1 | 417 Million USD | 2.71% |
| 1996 FY | 441 Million USD | 8.62% |
| 1996 Q4 | 441 Million USD | 2.08% |
| 1995 Q4 | 406 Million USD | 1.25% |
| 1995 FY | 406 Million USD | 42.46% |
| 1995 Q1 | 299 Million USD | 4.91% |
| 1995 Q2 | 395 Million USD | 32.11% |
| 1995 Q3 | 401 Million USD | 1.52% |
| 1994 Q3 | 273 Million USD | 5.81% |
| 1994 Q2 | 258 Million USD | 0.0% |
| 1994 FY | 285 Million USD | 16.33% |
| 1994 Q4 | 285 Million USD | 4.4% |
| 1994 Q1 | 258 Million USD | 5.31% |
| 1993 Q2 | 32.4 Million USD | -8.99% |
| 1993 Q4 | 245 Million USD | 76.26% |
| 1993 FY | 245 Million USD | 768.79% |
| 1993 Q1 | 35.6 Million USD | 26.24% |
| 1993 Q3 | 139 Million USD | 329.01% |
| 1992 FY | 28.2 Million USD | 147.37% |
| 1992 Q4 | 28.2 Million USD | 0.71% |
| 1992 Q3 | 28 Million USD | 93.1% |
| 1992 Q1 | 12.7 Million USD | 11.4% |
| 1992 Q2 | 14.5 Million USD | 14.17% |
| 1991 Q1 | 7.9 Million USD | -5.95% |
| 1991 Q4 | 11.4 Million USD | 10.68% |
| 1991 Q3 | 10.3 Million USD | 8.42% |
| 1991 Q2 | 9.5 Million USD | 20.25% |
| 1991 FY | 11.4 Million USD | 35.71% |
| 1990 Q4 | 8.4 Million USD | 13.51% |
| 1990 FY | 8.4 Million USD | 0.0% |
| 1990 Q3 | 7.4 Million USD | 42.31% |
| 1990 Q2 | 5.2 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Phreesia, Inc. | - USD | -Infinity% |
| Accuray Incorporated | 138.32 Million USD | -1361.062% |
| Align Technology, Inc. | 296.9 Million USD | -580.696% |
| Elevance Health Inc. | -46.33 Billion USD | 104.362% |
| AxoGen, Inc. | 23.02 Million USD | -8679.322% |
| Boston Scientific Corporation | 2.48 Billion USD | 18.639% |
| CVS Health Corporation | 18.02 Billion USD | 88.788% |
| Cardinal Health, Inc. | 14.95 Billion USD | 86.488% |
| Centene Corporation | - USD | -Infinity% |
| DaVita Inc. | 143.1 Million USD | -1312.25% |
| Hologic, Inc. | 679.8 Million USD | -197.293% |
| Humana Inc. | - USD | -Infinity% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | -431.448% |
| Laboratory Corporation of America Holdings | 474.6 Million USD | -325.832% |
| Masimo Corporation | 545 Million USD | -270.826% |
| McKesson Corporation | 21.13 Billion USD | 90.439% |
| Patterson Companies, Inc. | 782.89 Million USD | -158.143% |
| Quest Diagnostics Incorporated | 190 Million USD | -963.684% |
| ResMed Inc. | 822.25 Million USD | -145.789% |
| Henry Schein, Inc. | 1.81 Billion USD | -11.35% |
| Teladoc Health, Inc. | 29.51 Million USD | -6747.83% |
| Universal Health Services, Inc. | 216.98 Million USD | -831.388% |
| Veeva Systems Inc. | - USD | -Infinity% |
| Baxter International Inc. | 2.82 Billion USD | 28.435% |
| Becton, Dickinson and Company | 3.27 Billion USD | 38.252% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | -65.574% |
| Danaher Corporation | 2.59 Billion USD | 22.089% |
| Stryker Corporation | 4.84 Billion USD | 58.27% |
| Medtronic plc | 5.21 Billion USD | 61.261% |